Polycystisches Ovar - Versionsgeschichte

Ossip Groth am 16. April 2010 um 19:28 Uhr

2010-04-16T19:28:31Z

← Nächstältere Version		Version vom 16. April 2010, 19:28 Uhr
Zeile 6:		Zeile 6:
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|		\| align="left" width="800" \|
	<ref name="PMID10858183">The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12):989-93 (2000) PMID 10858183 </ref><ref name="PMID12882878">Diabetes issues in women and children: polycystic ovary syndrome. Diabetes Care 26(8):2457-63 (2003) PMID 12882878 </ref><ref name="PMID16728533">Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154(6):763-75 (2006) PMID 16728533 </ref><ref name="PMID15096648">Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) 229(5):369-77 (2004) PMID 15096648 </ref><ref name="PMID19126632">Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab 94(1):35-7 (2009) PMID 19126632 </ref><ref name="PMID18987279">Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 93(11):4218-20 (2008) PMID 18987279 </ref><ref name="PMID18178908">Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 93(1):34-6 (2008) PMID 18178908 </ref><ref name="PMID18056778">Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92(12):4546-56 (2007) PMID 18056778 </ref><ref name="PMID17284617">Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 92(4):1209-16 (2007) PMID 17284617 </ref><ref name="PMID17179197">Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787-96 (2007) PMID 17179197 </ref><ref name="PMID16940456">Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237-45 (2006) PMID 16940456 </ref><ref name="PMID16522691">Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660-6 (2006) PMID 16522691 </ref><ref name="PMID16492691">Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(5):1741-7 (2006) PMID 16492691 </ref><ref name="PMID16418211">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91(3):781-5 (2006) PMID 16418211 </ref><ref name="PMID16418209">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91(3):786-9 (2006) PMID 16418209 </ref><ref name="PMID16368745">Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941-5 (2006) PMID 16368745 </ref><ref name="PMID16263814">Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 91(1):22-4 (2006) PMID 16263814 </ref><ref name="PMID15623819">Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929-35 (2005) PMID 15623819 </ref><ref name="PMID15472165">Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89(10):4797-800 (2004) PMID 15472165 </ref><ref name="PMID14602740">Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 88(11):5137-44 (2003) PMID 14602740 </ref><ref name="PMID11061494">Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? J Clin Endocrinol Metab 85(10):3520-5 (2000) PMID 11061494 </ref><ref name="PMID10372683">Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897-9 (1999) PMID 10372683 </ref><ref name="PMID9626128">Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976-87 (1998) PMID 9626128 </ref><ref name="PMID1556225">ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? J Clin Pathol 45(3):188-92 (1992) PMID 1556225 </ref><ref name="PMID12098657">Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1-5 (2002) PMID 12098657 </ref><ref name="PMID18480528">Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54(2):115-25 (2008) PMID 18480528 </ref><ref name="PMID15235215">Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50(2):140-4 (2004) PMID 15235215 </ref><ref name="PMID10379878">Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 13(6):800-5 (1999) PMID 10379878 </ref>		<ref name="PMID10858183">The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12):989-93 (2000) PMID 10858183 </ref><ref name="PMID12882878">Diabetes issues in women and children: polycystic ovary syndrome. Diabetes Care 26(8):2457-63 (2003) PMID 12882878 </ref><ref name="PMID16728533">Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154(6):763-75 (2006) PMID 16728533 </ref><ref name="PMID15096648">Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) 229(5):369-77 (2004) PMID 15096648 </ref><ref name="PMID19126632">Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab 94(1):35-7 (2009) PMID 19126632 </ref><ref name="PMID18987279">Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 93(11):4218-20 (2008) PMID 18987279 </ref><ref name="PMID18178908">Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 93(1):34-6 (2008) PMID 18178908 </ref><ref name="PMID18056778">Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92(12):4546-56 (2007) PMID 18056778 </ref><ref name="PMID17284617">Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 92(4):1209-16 (2007) PMID 17284617 </ref><ref name="PMID17179197">Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787-96 (2007) PMID 17179197 </ref><ref name="PMID16940456">Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237-45 (2006) PMID 16940456 </ref><ref name="PMID16522691">Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660-6 (2006) PMID 16522691 </ref><ref name="PMID16492691">Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(5):1741-7 (2006) PMID 16492691 </ref><ref name="PMID16418211">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91(3):781-5 (2006) PMID 16418211 </ref><ref name="PMID16418209">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91(3):786-9 (2006) PMID 16418209 </ref><ref name="PMID16368745">Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941-5 (2006) PMID 16368745 </ref><ref name="PMID16263814">Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 91(1):22-4 (2006) PMID 16263814 </ref><ref name="PMID15623819">Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929-35 (2005) PMID 15623819 </ref><ref name="PMID15472165">Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89(10):4797-800 (2004) PMID 15472165 </ref><ref name="PMID14602740">Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 88(11):5137-44 (2003) PMID 14602740 </ref><ref name="PMID11061494">Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? J Clin Endocrinol Metab 85(10):3520-5 (2000) PMID 11061494 </ref><ref name="PMID10372683">Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897-9 (1999) PMID 10372683 </ref><ref name="PMID9626128">Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976-87 (1998) PMID 9626128 </ref><ref name="PMID1556225">ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? J Clin Pathol 45(3):188-92 (1992) PMID 1556225 </ref><ref name="PMID12098657">Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1-5 (2002) PMID 12098657 </ref><ref name="PMID18480528">Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54(2):115-25 (2008) PMID 18480528 </ref><ref name="PMID15235215">Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50(2):140-4 (2004) PMID 15235215 </ref><ref name="PMID10379878">Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 13(6):800-5 (1999) PMID 10379878 </ref><ref name="PMID15561799">The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26(2):251-82 (2005) PMID 15561799 </ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''

Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“

2010-04-15T14:21:28Z

Die Seite wurde neu angelegt: „miniatur|Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“

Neue Seite

[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]
{| class="wikitable" |
| bgcolor="#dfdfdf" | '''Siehe auch'''
| align="left" width="800" |
|-
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| align="left" width="800" |
<ref name="PMID10858183">The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12):989-93 (2000) PMID 10858183 </ref><ref name="PMID12882878">Diabetes issues in women and children: polycystic ovary syndrome. Diabetes Care 26(8):2457-63 (2003) PMID 12882878 </ref><ref name="PMID16728533">Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154(6):763-75 (2006) PMID 16728533 </ref><ref name="PMID15096648">Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) 229(5):369-77 (2004) PMID 15096648 </ref><ref name="PMID19126632">Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab 94(1):35-7 (2009) PMID 19126632 </ref><ref name="PMID18987279">Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 93(11):4218-20 (2008) PMID 18987279 </ref><ref name="PMID18178908">Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 93(1):34-6 (2008) PMID 18178908 </ref><ref name="PMID18056778">Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92(12):4546-56 (2007) PMID 18056778 </ref><ref name="PMID17284617">Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 92(4):1209-16 (2007) PMID 17284617 </ref><ref name="PMID17179197">Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787-96 (2007) PMID 17179197 </ref><ref name="PMID16940456">Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237-45 (2006) PMID 16940456 </ref><ref name="PMID16522691">Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660-6 (2006) PMID 16522691 </ref><ref name="PMID16492691">Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(5):1741-7 (2006) PMID 16492691 </ref><ref name="PMID16418211">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91(3):781-5 (2006) PMID 16418211 </ref><ref name="PMID16418209">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91(3):786-9 (2006) PMID 16418209 </ref><ref name="PMID16368745">Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941-5 (2006) PMID 16368745 </ref><ref name="PMID16263814">Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 91(1):22-4 (2006) PMID 16263814 </ref><ref name="PMID15623819">Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929-35 (2005) PMID 15623819 </ref><ref name="PMID15472165">Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89(10):4797-800 (2004) PMID 15472165 </ref><ref name="PMID14602740">Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 88(11):5137-44 (2003) PMID 14602740 </ref><ref name="PMID11061494">Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? J Clin Endocrinol Metab 85(10):3520-5 (2000) PMID 11061494 </ref><ref name="PMID10372683">Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897-9 (1999) PMID 10372683 </ref><ref name="PMID9626128">Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976-87 (1998) PMID 9626128 </ref><ref name="PMID1556225">ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? J Clin Pathol 45(3):188-92 (1992) PMID 1556225 </ref><ref name="PMID12098657">Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1-5 (2002) PMID 12098657 </ref><ref name="PMID18480528">Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54(2):115-25 (2008) PMID 18480528 </ref><ref name="PMID15235215">Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50(2):140-4 (2004) PMID 15235215 </ref><ref name="PMID10379878">Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 13(6):800-5 (1999) PMID 10379878 </ref>
|-
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Medline Suchterm/ Synonyme'''
| align="left" width="800"|
|-
| bgcolor="#00dfdf" | '''Was ist das'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Struktur'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Physiologie'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Knockout'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Transgen'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Mutation'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Polymorphismus'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Genexpression'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Inhibitoren'''
| align="left" width="800"|
|-
| bgcolor="#dfdfdf" | '''Agonisten'''
| align="left" width="800"|
|}

----

== Bibliographie ==
<references />

{{LinkWP_Miniartikel|Txt=Polycystisches Ovar|Link=Polyzystisches Ovarialsyndrom}}